Summary
The aim of this study was to fabricate biomatrix/polymer hybrid scaffolds using an electrospinning technique. Then tissue engineered heart valves were engineered by seeding mesenchymal stromal cells (MSCs) onto the scaffolds. The effects of the hybrid scaffolds on the proliferation of seed cells, formation of extracellular matrix and mechanical properties of tissue engineered heart valves were investigated. MSCs were obtained from rats. Porcine aortic heart valves were decellularized, coated with poly(3-hydroxybutyrate-co-4-hydroxybutyrate) using an electrospinning technique, and reseeded and cultured over a time period of 14 days. In control group, the decellularized valve scaffolds were reseeded and cultured over an equivalent time period. Specimens of each group were examined histologically (hematoxylin-eosin [HE] staining, immunohistostaining, and scanning electron microscopy), biochemically (DNA and 4-hydroxyproline) and mechanically. The results showed that recellularization was comparable to the specimens of hybrid scaffolds and controls. The specimens of hybrid scaffolds and controls revealed comparable amounts of cell mass and 4-hydroxyproline (P>0.05). However, the specimens of hybrid scaffolds showed a significant increase in mechanical strength, compared to the controls (P<0.05). This study demonstrated the superiority of the hybrid scaffolds to increase the mechanical strength of tissue engineered heart valves. And compared to the decellularized valve scaffolds, the hybrid scaffolds showed similar effects on the proliferation of MSCs and formation of extracellular matrix. It was believed that the hybrid scaffolds could be used for the construction of tissue engineered heart valves.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Schmidt D, Stock UA, Hoerstrup SP. Tissue engineering of heart valves using decellularized xenogeneic or polymeric starter matrices. Philos Trans R Soc Lond B Biol Sci, 2007, 362(1484): 1505–1512
Schmidt D, Mol A, Breymann C, et al. Living autologous heart valves engineered from human prenatally harvested progenitors. Circulation, 2006,114(1 Suppl):125–131
Wu H, Wan Y, Cao XY, et al. Proliferation of chondrocytes on porous poly(DL-lactide)/chitosan scaffolds. Acta Biomaterialia, 2008,4(1):76–87
Stock UA, Schenke-Layland K. Performance of decellularized xenogeneic tissue in heart valve replacement. Biomaterials, 2006,27(1):1–2
Knight RL, Wilcox HE, Korossis SA, et al. The use of acellular matrices for the tissue engineering of cardiac valves. Proc Inst Mech Eng [H], 2008,222(1):129–143
Lichtenberg A, Cebotari S, Tudorache I, et al. Biological scaffolds for heart valve tissue engineering. Methods Mol Med, 2007,140():309–317
Jiang XG, Xu P, Han X, et al. Biophysics of acellular porcine valved conduits by decellularization with poly ethylene glycol. Acta Med Univ Sci Technol Huazhong (Chinese), 2006,35(5):659–661
Dong NG, Ye XF, Shi JW, et al. Comparison on decellularizing methods of biological scaffold with porcine aortic valve for tissue engineering heart valve. Chin J Exp Surg (Chinese), 2005,22(3):377–
Zhang J, Qi HX, Wang HJ, et al. Engineering of vascular grafts with genetically modified bone marrow mesenchymal stem cells on poly(propylene carbonate) graft. Artificial Organs, 2006,30(12):898–905
Kadnera A, Hoerstrupa SP, Zund G, et al. A new source for cardiovascular tissue engineering: human bone marrow stromal cells. Eur J Cardiothorac Surg, 2002, 21(6):1055–1060
Stock UA, Wiederschain D, Kilroy SM, et al. Dynamics of extracellular matrix production and turnover in tissue engineered cardiovascular structures. J Cell Biochem, 2001,81(2):220–228
Schenke-Layland K, Opitz F, Gross M, et al. Complete dynamic repopulation of decellularized heart valves by application of defined physical signals—an in vitro study. Cardiovasc Res, 2003,60(3):497–509
Korkusuz F, Korkusuz P, Eksioglu F, et al. In vivo response to biodegradable controlled antibiotic release systems. J Biomed Mater Res, 2001,55(2):217–228
Franconi F, Miceli M, Alberti L, et al. Effect of gamma-hydroxybutyric acid on human platelet aggregation in vitro. Thromb Res, 2001,102(3):255–260.
Stitzel J, Liu J, Lee SJ, et al. Controlled fabrication of a biological vascular substitute. Biomaterials, 2006,27(7): 1088–1094
Williamson MR, Black R, Kielty C. PCL-PU composite vascular scaffold production for vascular tissue engineering: attachment, proliferation and bioactivity of human vascular endothelial cells. Biomaterials, 2006,27(19): 3608–3616
Author information
Authors and Affiliations
Additional information
This project was supported by grants from National Natural Sciences Foundation of China (No. 30571839, 30600608 and 30872540) and National High Technology Research and Development Program (“863” Program) of China (No. 2009AA-03Z420).
Rights and permissions
About this article
Cite this article
Hong, H., Dong, N., Shi, J. et al. Fabrication of a novel hybrid scaffold for tissue engineered heart valve. J. Huazhong Univ. Sci. Technol. [Med. Sci.] 29, 599–603 (2009). https://doi.org/10.1007/s11596-009-0513-6
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11596-009-0513-6